Novartis(NVS) - 2024 Q1 - Earnings Call Transcript

Vas Narasimhan Next question, operator? Operator Thank you. Your next question comes from the line of Emily Field from Barclays. Please go ahead. Emily Field Hi. Thanks for taking my question. I just want to ask a question on Cosentyx. I know you mentioned you're expecting the J-code, but are you currently generating much sales from the IV formulation? Just in that context, if you could frame the current pricing environment in the U.S. specifically? Thank you. Vas Narasimhan Yeah, thanks, Emily. So, Cosenty ...